Med spa economics run on the gap between the first treatment and the annuity behind it. An injectable appointment books $300 to $700, laser packages run $900 to $2,500, and the categories are habit-forming by design: toxin patients return roughly quarterly, filler annually, and membership programs turn both into scheduled revenue. First-visit lead math undersells this vertical badly.
Treatment mix moves the math more than location does. Injector-led practices with high toxin volume see steady mid-hundreds tickets and strong retention; device-led practices (laser hair removal, body contouring) sell larger packages upfront with less recurrence. Both models advertise well, but they justify different lead prices, so the average-value input here should reflect your actual first-purchase mix, with the repeat toggle carrying the retention story.
Consult-to-treatment conversion is the vertical's close rate, and it rewards operational polish: online booking, deposits to hold appointments, and same-week availability. Practices taking deposits report meaningfully lower no-show rates on paid leads, which matters because the aesthetic-consult no-show is the single biggest leak in med spa lead spend.
Worked example
A worked example: a spa averaging $550 first treatments at 60% margin keeps $330 per new client. Converting 35% of inquiries into showed appointments makes a lead worth $116; the divide-by-three ceiling is about $39, mid-band. Count regular repeat (2.8x for this category) and the ceiling reaches $108, above the expensive end, which is the honest case for treating aesthetics patients as relationships rather than transactions.
The compliance caveat particular to aesthetics: health-adjacent advertising carries platform restrictions on claims and imagery, and violations pause accounts at exactly the moment a promotion peaks. The operational fix is boring: pre-approved creative variants ready to rotate, so a flagged ad never stops the calendar from filling.